Angiotech Pharmaceuticals, Inc. (ANPI) Adjusts for Remainder of 2008
Angiotech Pharmaceuticals (ANPI), a global specialty pharmaceutical and medical device company, announced its financial results for the first quarter 2008. Angiotech reported a $3.9 million loss for the first quarter, which equals a 5 cent loss per share. Analysts had projected a loss of 3 cents per share. Angiotech made a number changes in their internal control systems to strengthen their financial reporting process and reduce the incidence of errors. The weakness in the process was described in the March 13, 2008 release that announced the company’s 2007 year-end financial results. Angiotech has engaged a large public accounting firm to…